ACWEX | FIKAX | ACWEX / FIKAX | |
Total Expense Ratio | 1.93 | 0.58 | 333% |
Annual Report Gross Expense Ratio | 2.21 | 0.58 | 381% |
Fund Existence | 11 years | 7 years | - |
Gain YTD | 1.541 | 6.286 | 25% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 109M | 1.08B | 10% |
Annual Yield % from dividends | 0.50 | 0.99 | 51% |
Returns for 1 year | 0.80 | -5.70 | -14% |
Returns for 3 years | 21.06 | 28.68 | 73% |
Returns for 5 years | 238.46 | 294.41 | 81% |
Returns for 10 years | 60.27 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PPH | 88.89 | -0.33 | -0.37% |
VanEck Pharmaceutical ETF | |||
IAE | 6.07 | -0.09 | -1.38% |
VOYA ASIA PACIFIC HIGH DIVIDEND EQUITY Income FUND | |||
FEP | 40.37 | -0.81 | -1.97% |
First Trust Europe AlphaDEX® ETF | |||
IVRA | 15.84 | -0.55 | -3.35% |
Invesco Real Assets ESG ETF | |||
URTH | 148.28 | -6.35 | -4.11% |
iShares MSCI World ETF |